Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gregory B. Brown currently holds 50,500 shares of Caladrius Biosciences, Inc. (CLBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory B. Brown has been a net seller of CLBS stock. They have purchased $0 and sold $540.9K worth of shares.
Gregory B. Brown's most recent insider trade was on Jun 10, 2026, when they sold 50,500 shares at $0.00 per share.
Gregory B. Brown serves as Executive at Caladrius Biosciences, Inc. (CLBS). They have executed 21 insider transactions totaling $540.9K over their tenure at the company.
Gregory B. Brown holds the position of Executive at Caladrius Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Gregory B. Brown has shown a selling trading pattern, with $0 in total purchases and $540.9K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gregory B. Brown was on Dec 4, 2019, when they sold $540.9K worth of CBM shares. This transaction involved 9,015 shares at $60.00 per share.
Gregory B. Brown currently owns 50,500 shares of Caladrius Biosciences, Inc. (CLBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gregory B. Brown's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gregory B. Brown has 21 Form 4 filings on record as an insider at Caladrius Biosciences, Inc..
Set alerts for Gregory B. Brown and 40,000+ other insiders.